Annie Yoshiyama
Förmögenhet: 258 995 $ per 2026-06-30
Förmögenhet: 258 995 $ per 2026-06-30
Annie Yoshiyama currently works at Allogene Therapeutics, Inc., as Senior Vice President & Controller from 2024.
Ms. Yoshiyama also formerly worked at Tricida, Inc., as Chief Accounting Officer & Vice President-Finance, Dolby Laboratories, Inc., as Senior Financial Reporting from 2008 to 2018, and AN2 Therapeutics, Inc., as Vice President-Finance & Controller from 2023 to 2024.
Ms. Yoshiyama received her undergraduate degree and graduate degree from the University of Southern California.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-21 | 124 517 ( 0,04 % ) | 258 995 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Comptroller/Controller/Revisor | 2024-06-05 |
| Företag | Position | Slut |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Comptroller/Controller/Revisor | 2024-03-01 |
| TRICIDA, INC. | Comptroller/Controller/Revisor | 2023-09-01 |
| DOLBY LABORATORIES, INC. | Företagsledare/Principal | 2018-06-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Tricida, Inc.
Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dolby Laboratories, Inc.
Dolby Laboratories, Inc. Packaged SoftwareTechnology Services Develops audio and imaging technologies and products for cinema, television, broadcast & entertainment industries | Technology Services |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån